The history of Viagra, initially marketed by copyright, presents a intricate case study for investors considering the pharmaceutical sector. Despite its initial success and impact of vast in revenue , the intellectual property lapse has opened the floodgates for competing medications, greatly diminishing income potential . This transition raises do